Daren Tang announced that the company plans to transfer 4.6% of the shares and 7.4% of the shares of Sino-US Tianjin Schke Pharmaceutical Co., Ltd. to Helion Co., Ltd. and Haleon CHSARL, respectively. The transaction prices are 622 million yuan and 1,001 billion yuan respectively. According to preliminary estimates, the transaction is expected to affect the company's current investment income of about 1.54 billion yuan. After the transfer was completed, the company no longer held shares in Tianjin.

Zhitongcaijing · 04/15 09:25
Daren Tang announced that the company plans to transfer 4.6% of the shares and 7.4% of the shares of Sino-US Tianjin Schke Pharmaceutical Co., Ltd. to Helion Co., Ltd. and Haleon CHSARL, respectively. The transaction prices are 622 million yuan and 1,001 billion yuan respectively. According to preliminary estimates, the transaction is expected to affect the company's current investment income of about 1.54 billion yuan. After the transfer was completed, the company no longer held shares in Tianjin.